Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon L Goodman

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Experimental and Therapeutic Medicine|September 15, 2012
Immunohistochemical analysis of integrins αvβ3, αvβ5 and α5β1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomasEva-Maria Fabricius, Gustav-Paul Wildner, Ute Kruse-Boitschenko, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 16, 2014
Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancerChristine Böger, Viktoria S Warneke, Hans-Michael Behrens, et al.
Journal of Neuropathology and Experimental Neurology|February 13, 2013
Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factorJens Schittenhelm, Esther I Schwab, Jan Sperveslage, et al.
Hepatology (Baltimore, Md.)|September 3, 2009
Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesisEleonora Patsenker, Yury Popov, Felix Stickel, et al.
Nature Structural & Molecular Biology|March 25, 2014
Structural basis for pure antagonism of integrin αVβ3 by a high-affinity form of fibronectinJohannes F Van Agthoven, Jian-Ping Xiong, José Luis Alonso, et al.
International Journal of Cancer|August 23, 2005
Monitoring multiple angiogenesis-related molecules in the blood of cancer patients shows a correlation between VEGF-A and MMP-9 levels before treatment and divergent changes after surgical vs. conservative therapyKhalil Zaman, Robert Driscoll, Diane Hahn, et al.
Brain : a Journal of Neurology|February 5, 2013
Integrin control of the transforming growth factor-β pathway in glioblastomaPatrick Roth, Manuela Silginer, Simon L Goodman, et al.
Neuro-Oncology|October 3, 2013
Invasion patterns in brain metastases of solid cancersAnna S Berghoff, Orsolya Rajky, Frank Winkler, et al.
International Journal of Cancer|February 10, 2009
Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependencyTom Mikkelsen, Chaya Brodie, Susan Finniss, et al.
Cancer Research|October 19, 2005
Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are criticalRiccardo E Nisato, Ghamartaj Hosseini, Christian Sirrenberg, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Experimental and Therapeutic Medicine|September 15, 2012
Immunohistochemical analysis of integrins αvβ3, αvβ5 and α5β1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomasEva-Maria Fabricius, Gustav-Paul Wildner, Ute Kruse-Boitschenko, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 16, 2014
Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancerChristine Böger, Viktoria S Warneke, Hans-Michael Behrens, et al.
Journal of Neuropathology and Experimental Neurology|February 13, 2013
Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factorJens Schittenhelm, Esther I Schwab, Jan Sperveslage, et al.
Hepatology (Baltimore, Md.)|September 3, 2009
Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesisEleonora Patsenker, Yury Popov, Felix Stickel, et al.
Nature Structural & Molecular Biology|March 25, 2014
Structural basis for pure antagonism of integrin αVβ3 by a high-affinity form of fibronectinJohannes F Van Agthoven, Jian-Ping Xiong, José Luis Alonso, et al.
International Journal of Cancer|August 23, 2005
Monitoring multiple angiogenesis-related molecules in the blood of cancer patients shows a correlation between VEGF-A and MMP-9 levels before treatment and divergent changes after surgical vs. conservative therapyKhalil Zaman, Robert Driscoll, Diane Hahn, et al.
Brain : a Journal of Neurology|February 5, 2013
Integrin control of the transforming growth factor-β pathway in glioblastomaPatrick Roth, Manuela Silginer, Simon L Goodman, et al.
Neuro-Oncology|October 3, 2013
Invasion patterns in brain metastases of solid cancersAnna S Berghoff, Orsolya Rajky, Frank Winkler, et al.
International Journal of Cancer|February 10, 2009
Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependencyTom Mikkelsen, Chaya Brodie, Susan Finniss, et al.
Cancer Research|October 19, 2005
Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are criticalRiccardo E Nisato, Ghamartaj Hosseini, Christian Sirrenberg, et al.
Pageof 5